Next Article in Journal
B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia
Previous Article in Journal
Inflammatory Pseudotumors after Stem Cell Transplantation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 7
Issue 3
10.4081/hr.2015.5927
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria

by
Hassan A. Al-Jafar
*,
Salma M. AlDallal
,
Haifa A. Askar
,
Ali M. Aljeraiwi
and
Ahmad Al-Alansari
Department of Hematology, Amiri Hospital, Kuwait City 25, Kuwait
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2015, 7(3), 5927; https://doi.org/10.4081/hr.2015.5927
Submission received: 26 March 2015 / Revised: 13 August 2015 / Accepted: 2 September 2015 / Published: 23 September 2015

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an ultra-orphan disease affecting all hematopoietic cell types. The abnormality of red blood cells in this disease predisposes to intravascular complement-mediated hemolysis. Eculizumab is an orphan drug used to treat this rare disease. Thrombosis is the key cause of death in PNH patients in about 40% to 67% of cases. We report the case of a woman presenting with PNH complicated with serious Budd-Chiari syndrome thrombosis and with a stent inserted in the portal vein. She refused to take any anticoagulant treatment since she commenced eculizumab 4 years before. No thrombotic events happened since that time. This case could add an extra benefit for eculizumab, which could be used as an anti-thromboembolic prophylactic agent in PNH, especially in patients with thrombocytopenia, where the use of anticoagulant agents is extremely hazardous. More randomized studies might establish the use of eculizumab without anticoagulants to avoid serious bleeding that could happen in thrombocytopenic PNH patients.
Keywords: aroxysmal nocturnal hemoglobinuria; eculizumab; thrombosis; orphan; anticoagulant aroxysmal nocturnal hemoglobinuria; eculizumab; thrombosis; orphan; anticoagulant

Share and Cite

MDPI and ACS Style

Al-Jafar, H.A.; AlDallal, S.M.; Askar, H.A.; Aljeraiwi, A.M.; Al-Alansari, A. Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria. Hematol. Rep. 2015, 7, 5927. https://doi.org/10.4081/hr.2015.5927

AMA Style

Al-Jafar HA, AlDallal SM, Askar HA, Aljeraiwi AM, Al-Alansari A. Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria. Hematology Reports. 2015; 7(3):5927. https://doi.org/10.4081/hr.2015.5927

Chicago/Turabian Style

Al-Jafar, Hassan A., Salma M. AlDallal, Haifa A. Askar, Ali M. Aljeraiwi, and Ahmad Al-Alansari. 2015. "Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria" Hematology Reports 7, no. 3: 5927. https://doi.org/10.4081/hr.2015.5927

APA Style

Al-Jafar, H. A., AlDallal, S. M., Askar, H. A., Aljeraiwi, A. M., & Al-Alansari, A. (2015). Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria. Hematology Reports, 7(3), 5927. https://doi.org/10.4081/hr.2015.5927

Article Metrics

Back to TopTop